DBV TECHNOLOGIES SADBV TECHNOLOGIES SADBV TECHNOLOGIES SA

DBV TECHNOLOGIES SA

No trades
See on Supercharts
Market capitalization
‪123.24 M‬EUR
−0.71EUR
‪−67.27 M‬EUR
‪72.54 M‬
Beta (1Y)
0.36

About DBV TECHNOLOGIES SA

CEO
Daniel Tassé
Headquarters
Montrouge
Employees (FY)
104
Founded
2002
ISIN
FR0010417345
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DBV is 1.26 EUR — it has decreased by 2.77% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange DBV TECHNOLOGIES SA stocks are traded under the ticker DBV.
DBV TECHNOLOGIES SA is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for DBV TECHNOLOGIES SA has a max estimate of 18.25 EUR and a min estimate of 1.37 EUR.
DBV earnings for the last quarter are −0.32 EUR whereas the estimation was −0.43 EUR which accounts for 25.16% surprise. Estimated earnings for the next quarter are −0.43 EUR. See more details about DBV TECHNOLOGIES SA earnings.
DBV TECHNOLOGIES SA revenue for the last quarter amounts to ‪2.28 M‬ EUR despite the estimated figure of ‪1.18 M‬ EUR. In the next quarter revenue is expected to reach ‪1.09 M‬ EUR.
Yes, you can track DBV TECHNOLOGIES SA financials in yearly and quarterly reports right on TradingView.
Like other stocks, DBV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DBV TECHNOLOGIES SA stock right from TradingView charts — choose your broker and connect to your account.
DBV reached its all-time high on Jan 19, 2021 with the price of 13.28 EUR, and its all-time low was 1.27 EUR and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 104.00 employees. See our rating of the largest employees — is DBV TECHNOLOGIES SA on this list?